Quick Summary:
In the dynamic and complex landscape of Sexually Transmitted Diseases' (STDs) diagnostic testing, keeping current with market trends, new technological advancements, and regulatory environment can be challenging. As the prevalence of STDs increases worldwide, there is a growing demand for effective diagnostic testing, fueled by government funding and novel product launches. The global diagnostic testing of STDs market report provides a comprehensive analysis of the current market trends and an extensive outlook for future developments.
Stay ahead in this competitive market, gain expert insights about key drivers, restraints, opportunities, and emerging market trends. The report offers an in-depth analysis of market dynamics, segmented across test types and regions, making it a vital resource for stakeholders, including product manufacturers, investors, suppliers, and distributors. Profit from vital intelligence about key players, their products, financial performance, and strategic initiatives to inform your investment and expansion decisions. Gain significant insights about potential revenue opportunities in various market segments and make informed choices about upcoming product launches and marketing strategies.
Market Dynamics
The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.Key features of the study:
- This report provides an in-depth analysis of the global diagnostic testing of STDs market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global diagnostic testing of STDs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
- The global diagnostic testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic testing of STDs market.
Detailed Segmentation:
Global Diagnostic Testing of STDs Market, By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
Global Diagnostic Testing of STDs Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- Vela Diagnostics USA Inc.
- Roche Holdings AG
- Alere, Inc.
- Becton Dickinson & Company
- bioMerieux
- Danaher Corporation (Beckman Coulter)
- Hologic, Inc.
- binx health
- Chembio Diagnostics
- Pinpoint Science Inc.
- bioLytical Laboratories
What is the estimated value of the Global Diagnostic Testing of STDs Market?
What is the growth rate of the Global Diagnostic Testing of STDs Market?
What is the forecasted size of the Global Diagnostic Testing of STDs Market?
Who are the key companies in the Global Diagnostic Testing of STDs Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | June 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 10.4 Billion |
| Forecasted Market Value ( USD | $ 19.8 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Vela Diagnostics USA Inc.
- Roche Holdings AG
- Alere, Inc.
- Becton Dickinson & Company
- bioMerieux
- Danaher Corporation (Beckman Coulter)
- Hologic, Inc.
- binx health
- Chembio Diagnostics
- Pinpoint Science Inc.
- bioLytical Laboratories
